New JAMA COVID-19 Vaccine Study Misses the Mark
-
New JAMA COVID-19 Vaccine Study Misses the Mark
“The bottom line is that the study does not provide definitive evidence that COVID-19 vaccination broadly reduces cardiovascular risk.”
— Dr. Joseph Varon, IMA President and Chief Medical Officer
The Independent Medical Alliance (IMA), a national coalition of more than 12,000 physicians, researchers, and healthcare professionals, today urged caution when interpreting a recently published study in JAMA Internal Medicine that suggests the 2024-2025 COVID-19 vaccine is associated with a reduction in major adverse cardiovascular events among U.S. veterans.
While the pro-mRNA camp is promoting the study as evidence of cardiovascular benefits from COVID-19 vaccination, the study itself is not a randomized clinical trial, but rather merely an observational study.
“We cannot let politics drive the needed research and reconciliation needed from the COVID response era,” said Dr. Joseph Varon, President and Chief Medical Officer of the Independent Medical Alliance. “We need statistically accurate studies about what exactly is happening to patients who received mRNA and what future population impacts we should anticipate. What we don’t need are non-statistically valid samples which seem more focused on driving a narrative than finding the truth.”
To see the full article and find out what issues the IMA has with the JAMA study:
https://imahealth.org/new-jama-covid-19-vaccine-study-misses-the-mark/
Log in to reply.